Cleared Special

K181886 - VivaSight-DL System

K181886 is the FDA 510(k) clearance for VivaSight-DL System by Etview , Ltd.. It is a Class 2 Anesthesiology device (product code CBI) cleared through the Special 510(k) pathway after a 124-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
124d
Days
Class 2
Risk

K181886 is an FDA 510(k) clearance for the VivaSight-DL System. Classified as Tube, Tracheal/bronchial, Differential Ventilation (w/wo Connector) (product code CBI), Class II - Special Controls.

Submitted by Etview , Ltd. (Misgav Business Park, IL). The FDA issued a Cleared decision on November 14, 2018 after a review of 124 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5740 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Etview , Ltd. devices

Submission Details

510(k) Number K181886 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2018
Decision Date November 14, 2018
Days to Decision 124 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 140d · This submission: 124d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code CBI Tube, Tracheal/bronchial, Differential Ventilation (w/wo Connector)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5740
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Consultant

Qsite
Yoram Levy

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - CBI Tube, Tracheal/bronchial, Differential Ventilation (w/wo Connector)

All 19
Devices cleared under the same product code (CBI) and FDA review panel - the closest regulatory comparables to K181886.
sOLVe Tube
K201026 · Hytek Medical, Inc. · Aug 2021
Ambu VivaSight 2 DLT, Ambu VivaSight 2 Adapter Cable
K203749 · Ambu A/S · May 2021
ABC33L, ABC35L, ABC37L, ABC39L, ABC33R, ABC35R, ABC37R, ABC39R
K200968 · Insung Medical Co., Ltd. · Dec 2020
Sheridan Endobronchial Tubes
K180253 · Teleflex Medical · Nov 2018
5.0 Fr Arndt Endobronchial Blocker Set
K160542 · Cook Incorporated · Aug 2016
RUSCH ENDOBRONCHIAL TUBES
K141888 · Teleflexmedical, Inc. · Apr 2015